Joseph H. Crabb

Joseph H. Crabb is a declared insider of Immucell Corp (chief executive), with filings sourced from SEC (Form 4). Over a trading history stretching from 28 March 2006 to 9 March 2022, the count stands at 40 filings.

In open-market terms, that means 5 purchases worth €31k on one side and 29 sales worth €60k on the other. The net balance comes to €29k on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 3 option exercises.

The median purchase comes to €2,362. After 4 purchases with a full 90-day history, the hit rate stands at 50% and the median 90-day move at -0.6%. Past outcomes like these are no guarantee of what comes next.

Most recently, on 14 March 2022, the filings show a transaction worth €5,359 in Immucell Corp. The clock since the last published purchase (9 December 2011) now reads 5,449 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.